Frequently Asked Questions – Governance & Change

How are pathways and rules governed?

• Clinically defined and approved by the Trust
• Aligned to local SOPs
• Subject to formal governance and sign-off

How are changes managed?

1. Request raised
2. Impact assessment (clinical/operational)
3. Clinical approval
4. Configuration & testing
5. Controlled release

All changes are version-controlled and auditable.

How is clinical safety maintained over time?

Patients are assigned a priority score (e.g. P1–P5) based on responses and configured pathways. This supports early visibility of acuity and helps teams meet rapid initial assessment expectations.

What if the triage outcome looks incorrect?

Clinicians can review, override, and amend any outcome at any time. Opto does not constrain clinical decision-making.

Is Opto clinically safe?

Yes. Opto is developed and maintained in line with DCB0129 with:

• A maintained Clinical Safety Case Report
• A Hazard Log with defined mitigations
• Ongoing clinical governance and oversight
• Continuous monitoring and improvement based on real-world use